BILDERBEEK Richel
- None, None, Uppsala, Sweden
- Life Sciences
Recommendations: 0
Review: 1
Website
https://www.richelbilderbeek.nl/
Areas of expertise
Open Science, software development, theoretical biology, phylogenetics, immunology, GWAS / Genome Wide Association Study, genetic epidemiology, R, C++
Review: 1
23 Jan 2023
STAGE 1
Genetically-modified animals as models of neurodevelopmental conditions: an umbrella review
Evaluating the quality of systematic reviews in preclinical animal studies of neurodevelopmental conditions
Recommended by Chris Chambers based on reviews by Marietta Papadatou-Pastou and Richel BilderbeekSingle gene alterations have been estimated to account for nearly half of neurodevelopmental conditions (NDCs), providing a crucial opportunity for animal models to understand the underlying mechanisms, causes and potential treatments. The use of systematic reviews (SRs) can, in principle, provide a powerful means to synthesise this evidence-base; however, the reporting quality of previous SRs in preclinical animal research has been found lacking (Hunniford et al., 2021). In the current study, Wilson et al. (2023) will undertake an umbrella review – a systematic review of systematic reviews – to assess the characteristics and reporting quality of SRs that, in turn, synthesise research in genetically-modified animals to model NDCs. In particular, the authors will extract key features of reviews (including, among others, the aim and primary research questions, relevant animal model, and number of studies in the SR), in addition to quality indicators such as risk of bias and completeness of reporting. In doing so, the authors aim to enhance guidance on the conduct and reporting of systematic reviews in this area.
The Stage 1 manuscript was evaluated over two rounds of in-depth review. Based on detailed responses to the reviewers' comments, the recommender judged that the manuscript met the Stage 1 criteria and therefore awarded in-principle acceptance (IPA).
URL to the preregistered Stage 1 protocol: https://osf.io/952qk
URL to the preregistered Stage 1 protocol: https://osf.io/952qk
Level of bias control achieved: Level 4. At least some of the data/evidence that will be used to answer the research question already exists AND is accessible in principle to the authors BUT the authors certify that they have not yet accessed any part of that data/evidence.
List of eligible PCI RR-friendly journals:
- Brain and Neuroscience Advances
- F1000Research
- Human Population Genetics and Genomics
- In&Vertebrates
- Journal for Reproducibility in Neuroscience
- Peer Community Journal
- PeerJ
- Royal Society Open Science
References
1. Hunniford V. T., Montroy J., Fergusson D. A., Avey M. T., Wever K. E., McCann S. K., Foster M., Fox G., Lafreniere M., Ghaly M., Mannell S., Godwinska K., Gentles A., Selim S., MacNeil J., Sikora L., Sena E. S., Page M. J., Macleod M., Moher D., & Lalu M. M. (2021). Epidemiology and reporting characteristics of preclinical systematic reviews. PLOS Biology, 19:e3001177. https://doi.org/10.1371/journal.pbio.3001177
2. Wilson, E., Currie, G., Macleod, M., Kind, P. & Sena, E. S. (2023). Genetically-modified animals as models of neurodevelopmental conditions: an umbrella review, in principle acceptance of Version 3 by Peer Community in Registered Reports. https://osf.io/952qk